Vermilion Energy Inc.
NYSE:VETOil & Gas Exploration & Production
-$0.58 today
- Market cap
- $1.56B
- Beta
- 0.50
- P/E (TTM)
- -2.5
- EPS (TTM)
- -$5.33
- Dividend yield
- 3.91%
Volume 1.72M
Average 2.04M
VET Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Vermilion Energy Inc.NYSE: VET
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q2 FY2026 research & development was CA$0, compared with CA$0 a year earlier. Trailing-twelve-month research & development was CA$0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near CA$0 or moves back toward the trailing-twelve-month quarterly average of CA$0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
CAD · from the income statement
- Latest · FY2025
- 0 CAD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How VET compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for VET, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | CA$0 CAD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
NPKINPK International Inc. | LTM Mar 2026 | $0 USD | — | — | 0.0% |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding VET) | — | — | — | 0.0% | |
Competitors are the stored peer set for VET. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.23B | 3.72B | 2.2B | 2.07B | 1.76B |
| Cost of Revenue | 904.9M | 1.13B | 1.08B | 954.03M | 1.47B |
| Gross Profit | 1.32B | 2.59B | 1.12B | 1.12B | 290.9M |
| Gross Margin | 59.4% | 69.7% | 50.8% | 54.0% | 16.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 171.6M | 102.07M | 123.47M | 129.43M | 123.52M |
| Operating Expenses | 628.17M | 728.17M | 803.9M | 870.82M | 123.52M |
| Depreciation & Amortization | 571.69M | 577.13M | 712.62M | 683.24M | 768.46M |
| EBITDA | 2.03B | 2.71B | 519.55M | 761.26M | 576.55M |
| EBITDA Margin | 91.0% | 72.9% | 23.6% | 36.7% | 32.7% |
| Operating Income | 693.78M | 1.87B | 314.35M | 249.4M | 167.38M |
| Operating Margin | 31.2% | 50.1% | 14.3% | 12.0% | 9.5% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 73.08M | 82.86M | 85.21M | 84.61M | 132.64M |
| Other Income / Expenses | 688.11M | 186.02M | (592.63M) | (255.98M) | (491.93M) |
| Income Before Tax | 1.38B | 2.05B | (278.28M) | (6.59M) | (324.55M) |
| Pre-Tax Margin | 62.1% | 55.1% | -12.7% | -0.3% | -18.4% |
| Income Tax Expense | 233.2M | 738.04M | (40.7M) | 40.15M | 39.96M |
| Net Income | 1.15B | 1.31B | (237.59M) | (46.74M) | (653.07M) |
| Net Margin | 51.6% | 35.3% | -10.8% | -2.3% | -37.0% |
| EPS (Basic) | 7.13 | 8.03 | (1.45) | (0.30) | (4.24) |
| EPS (Diluted) | 6.97 | 7.80 | (1.45) | (0.30) | (4.24) |
| Weighted Avg Shares | 161.17M | 163.49M | 163.72M | 158.07M | 153.86M |
| Weighted Avg Shares (Diluted) | 164.77M | 168.43M | 163.72M | 158.07M | 153.86M |
Vermilion Energy Inc.
NYSE:VET
Intrinsic Alpha fair value
Locked
Current Price
$10.29
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.